UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C.  20549

                        ______________________________

                                   FORM 8-K
                          _________________________

                                CURRENT REPORT


    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): May 12, 2004



                        CARRINGTON LABORATORIES, INC.

            (Exact name of Registrant as specified in its charter)



               Texas                    0-11997             75-1435663
  -------------------------------     ----------         ----------------
  (State or other jurisdiction of     Commission         (I.R.S. Employer
  incorporation or organization)      File Number       Identification No.)


         2001 Walnut Hill Lane
             Irving, Texas                                    75038
 ----------------------------------------                   ----------
 (Address of principal executive offices)                   (Zip Code)

   Registrant's telephone number, including area code:  (972) 518-1300


                                 Not applicable
              ----------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)




 Item 7.  Financial Statements and Exhibits.

   Exhibit 99.1    Press Release dated May 12, 2004.


 Item 12.  Results of Operations and Financial Condition

 On May 12, 2004,  Carrington Laboratories, Inc.,  a  Texas corporation  (the
 "Company"), issued a press release describing  its financial results for the
 three-month period  ended March 31, 2004.  A copy  of  the  Company's  press
 release  has been furnished  as  Exhibit 99.1 to this Current Report on Form
 8-K.

 The information on this report shall not be treated as "filed" for  purposes
 of the Securities Exchange Act of 1934, as amended.



                                  SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934,
 the Registrant has duly caused this report to be signed on its behalf by the
 undersigned thereunto duly authorized.


                               CARRINGTON LABORATORIES, INC.



 Date: May 12, 2004            By:  /s/ Carlton E. Turner
                               -------------------------------------
                               Carlton E. Turner, Ph.D., D.Sc.
                               President and Chief Executive Officer



                              INDEX TO EXHIBITS

       Item     Exhibit

       99.1     Press Release dated May 12, 2004.